IDEXX Laboratories, Inc. IDXX

Healthcare — Diagnostics & Research

519.26 5.87 1.14% as of 25 Sep

Market cap: $40.2B
P/E: 36.2×

Follow IDXX

S&P 500 Member Cash Flow Champion (3y)

Indexes indicate stock being part of an index,

Growth Flags show if company had growth for consecutive years

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16
Cash and Short Term Investments	180.07	288.27	453.93	112.55	144.45	383.93	90.33	123.79	471.93	391.85
Receivables	552.38	473.58	457.45	400.62	368.35	331.43	269.31	248.86	234.60	204.49
Inventory	377.76	381.88	380.28	367.82	269.03	209.87	195.02	173.30	164.32	158.03
Other current assets	303.62	256.18	203.60	220.49	173.82	137.51	124.98	108.22	101.14	91.21
Total current assets	1,413.83	1,399.90	1,495.25	1,101.48	955.66	1,062.74	679.64	654.17	971.99	845.58
Property, Plant, Equpment (Net)	747.38	713.12	702.18	649.47	587.67	555.17	533.85	437.27	379.10	357.42
Goodwill and Intangible Assets (Total)	523.85	516.78	450.46	459.47	458.38	295.89	298.19	256.31	243.72	224.38
Long-term assets (Other)	542.48	547.52	496.53	417.73	330.40	289.60	240.19	189.59	118.62	103.32
Total non-current assets	1,936.93	1,893.55	1,764.67	1,645.29	1,481.55	1,231.82	1,152.84	883.18	741.43	685.12
Total Assets	3,350.76	3,293.44	3,259.93	2,746.77	2,437.20	2,294.56	1,832.48	1,537.35	1,713.42	1,530.70
Notes Payable	398.00	250.00	250.00	579.00	73.50	—	288.77	398.94	655.00	611.00
Accounts Payable	110.41	114.21	110.64	110.22	116.14	74.56	72.17	69.53	66.97	60.06
Accrued Expenses	530.15	502.12	478.71	433.66	458.91	415.65	322.94	260.68	253.42	236.13
Current Part of Debt	75.00	167.79	75.00	74.98	75.00	49.99	304.00	399.00	655.00	611.00
Current Revenue (Deferred)	35.26	33.80	37.20	37.94	40.03	42.57	41.46	41.29	29.18	27.38
Total current liabilities	1,148.81	1,067.92	951.55	1,235.80	763.58	582.76	725.34	770.44	1,004.57	934.57
Long Term Debt (Total)	374.84	449.79	622.88	694.39	775.21	858.49	698.91	601.35	606.08	593.11
Non-current Revenue (Deferred)	32.18	26.94	28.53	30.86	41.17	46.16	48.74	60.70	35.55	33.02
Long Term Tax Liability (Deferred)	31.87	11.31	7.24	8.15	8.94	11.71	33.02	29.27	25.35	39.29
Non-current Liabilities (Other)	56.53	44.34	65.53	67.59	70.94	85.60	81.16	84.83	95.72	38.94
Total non-current liabilities	596.56	630.21	823.85	902.23	983.63	1,079.01	929.31	776.14	762.69	704.35
Total liabilities	1,745.38	1,698.13	1,775.40	2,138.03	1,747.21	1,661.77	1,654.65	1,546.58	1,767.26	1,638.92
Additional Paid In Capital	1,826.75	1,673.86	1,569.57	1,463.22	1,377.32	1,294.85	1,213.52	1,138.22	1,073.93	1,011.90
Common Stock (Net)	10.84	10.78	10.75	10.72	10.69	10.65	10.57	10.51	10.43	10.33
Retained Earnings	6,391.90	5,332.44	4,444.57	3,599.53	2,920.44	2,175.60	1,595.65	1,167.93	803.55	540.40
Treasury Stock	6,561.36	5,334.01	4,474.68	4,392.11	3,570.69	2,799.89	2,600.54	2,288.90	1,911.53	1,633.44
Common Equity (Total)	1,605.38	1,595.31	1,484.53	608.74	689.99	632.79	177.82	(9.23)	(53.84)	(108.21)
Shareholders Equity (Total)	1,605.38	1,595.31	1,484.53	608.74	689.99	632.80	177.83	(9.23)	(53.84)	(108.21)
Shareholders Equity and Liabilities (Total)	3,350.76	3,293.44	3,259.93	2,746.77	2,437.20	2,294.56	1,832.48	1,537.35	1,713.42	1,530.70
Shares (Common)	79.71	81.60	83.03	82.89	84.56	85.45	85.47	86.10	87.10	87.97
Shareholders Equity (Tangible)	1,081.54	1,078.54	1,034.07	149.27	231.61	336.91	(120.37)	(265.55)	(297.56)	(332.60)
Net Debt	269.77	329.31	243.95	656.82	705.75	524.55	912.58	876.55	789.15	812.26
Total Debt	449.84	617.57	697.88	769.37	850.20	908.48	1,002.91	1,000.35	1,261.08	1,204.11

Show all line items

In millions of $ except per-share values · columns are period end dates

Powerpack

Full quarterly history

Analyst estimates

Unlimited screener

Unlimited Excel

Unlimited follows

IDEXX Laboratories, Inc. IDXX